In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

So, you want to get better at Python, huh? It’s a popular language, and for good reason. Whether you’re just starting out or trying to level up your skills, finding good places to practice is key.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Learning Python is a smart move these days. It’s used everywhere, from making websites to crunching numbers. The good news? You don’t need to spend a fortune to get started. There are tons of great, ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Anna Otto, a computer science and online learning coordinator, went right to the best expert she could think of when she was designing a short course about artificial intelligence for middle schoolers ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Artificial intelligence has been rapidly changing the K-12 education landscape—from providing opportunities for personalized learning to assisting with nonteaching tasks. As the new school year kicks ...